We found previously that ErbB2-driven downregulation of a pro-apoptotic protein PERP in breast tumor cells blocks their anoikis [26] and that various ErbB2 antagonists upregulate PERP in these cells [26]. This evidence concerns the gene ERBB2 and breast neoplasm.